Effect of Time-restricted Eating on Behaviour and Metabolism in Overweight Individuals at High Risk of Type 2 Diabetes

NCT03854656 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-03-18

No results posted yet for this study

Summary

The aim of the present study is to investigate effects of 12 weeks time-restricted eating on behaviour and metabolism in individuals with overweight or obesity at high risk of type 2 diabetes.

Conditions

Interventions

OTHER

Time-restricted eating

Participants will be instructed to eat within a self-selected 10-hour timeframe between 6AM and 8PM every day. All food/beverages except water must be consumed within the time-interval. Staff will help participants select a time-interval that fits into their daily life and optimally fulfil the following guiding principles: 1. The first food item/beverage of the day should optimally be ingested at least 2 hours after usual wake-up time 2. The last food item/beverage of the day should optimally be ingested at least 3 hours before usual bed time Diet is ad libitum and with no further dietary restrictions. Participants will receive advice about a healthy lifestyle according to the national dietary recommendations from the Danish Health Authority.

Sponsors & Collaborators

  • University of Copenhagen

    collaborator OTHER
  • Aalborg University Hospital

    collaborator OTHER
  • IMotions A/S

    collaborator INDUSTRY
  • University of Leeds

    collaborator OTHER
  • Salk Institute for Biological Studies

    collaborator OTHER
  • Kristine Færch

    lead OTHER

Principal Investigators

  • Kristine Færch, PhD · Steno Diabetes Center Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-25
Primary Completion
2022-03-02
Completion
2022-03-02

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03854656 on ClinicalTrials.gov